[CAS NO. 1848959-11-4]  TAS4464hydrochloride

Ships within Stock Price Qty Total
$0.00
$0.00
Please click "REQUEST A QUOTE" button if you need other sizes or custom synthesis
request a quote
If there is no stock, or you need other sizes or custom synthesis, please:

PRODUCTS SPECIFICATIONS [1848959-11-4]

Catalog
HY-128586A
Brand
MCE
CAS
1848959-11-4

DESCRIPTION [1848959-11-4]

Overview

MDLMFCD32067968
Molecular Weight542.97
Molecular FormulaC21H24ClFN6O6S
SMILESNC1=NC=NC2=C1C(C#CC3=C(F)C=CC=C3OCC)=CN2[C@@H]4O[C@H](CNS(=O)(N)=O)[C@@H](O)[C@H]4O.Cl

For research use only. We do not sell to patients.


Summary

TAS4464 (hydrochloride) is a highly potent and selective inhibitor of NEDD8 activating enzyme (NAE) , with an IC 50 of 0.955 nM [1] .


IC50 & Target

IC50:0.955 nM (NAE) [1]


Clinical Trial

NCT Number Sponsor Condition Start Date Phase
NCT02978235 Taiho Oncology, Inc.
Multiple Myeloma|NonHodgkin Lymphoma
March 1, 2017 Phase 1

Appearance

Solid


Shipping

Room temperature in continental US; may vary elsewhere.


Storage

4°C, sealed storage, away from moisture

* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)


Solvent & Solubility

In Vitro:

DMSO : 83.33 mg/mL ( 153.47 mM ; Need ultrasonic)

H 2 O : 5 mg/mL ( 9.21 mM ; ultrasonic and warming and heat to 60°C)

Preparing
Stock Solutions
Concentration Solvent Mass 1 mg 5 mg 10 mg
1 mM 1.8417 mL 9.2086 mL 18.4172 mL
5 mM 0.3683 mL 1.8417 mL 3.6834 mL
10 mM 0.1842 mL 0.9209 mL 1.8417 mL
* Please refer to the solubility information to select the appropriate solvent.
In Vivo:
  • 1.

    Add each solvent one by one: 10% DMSO >> 40% PEG300 >> 5% Tween-80 >> 45% saline

    Solubility: ≥ 2.08 mg/mL (3.83 mM); Clear solution

  • 2.

    Add each solvent one by one: 10% DMSO >> 90% (20% SBE-β-CD in saline)

    Solubility: ≥ 2.08 mg/mL (3.83 mM); Clear solution

  • 3.

    Add each solvent one by one: 10% DMSO >> 90% corn oil

    Solubility: ≥ 2.08 mg/mL (3.83 mM); Clear solution

* All of the co-solvents are available by MCE.